AU Patent

AU2015204313B2 — Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

Assigned to Takeda Pharmaceuticals USA Inc · Expires 2017-11-16 · 9y expired

What this patent protects

NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS Abstract The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.

USPTO Abstract

NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS Abstract The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015204313B2
Jurisdiction
AU
Classification
—
Expires
2017-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceuticals USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.